Related Experiment Videos
Interaction of ranitidine with liver microsomes.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|January 1, 1982
Summary
Ranitidine interacts with cytochrome P-450 enzymes, affecting drug metabolism. This study details ranitidine
Area of Science:
- Pharmacology
- Biochemistry
- Drug Metabolism
Background:
- Cytochrome P-450 (CYP450) enzymes are crucial for drug metabolism.
- Ranitidine is a widely used medication that may interact with CYP450 enzymes.
Purpose of the Study:
- To investigate the interaction between ranitidine and rat liver cytochrome P-450.
- To determine the effect of ranitidine on the metabolic activity of CYP450 enzymes.
Main Methods:
- Spectroscopic analysis (difference optical spectra, e.p.r. spectra) of CYP450-ranitidine interactions.
- Enzyme kinetics studies to assess inhibition of O-dealkylation reactions.
- Determination of inhibition constants (Kii, Kis) and IC50 values.
Main Results:
- Ranitidine forms distinct spectral complexes with CYP450, indicating binding.
- Ranitidine inhibits the O-dealkylation of 7-ethoxycoumarin and p-nitroanisole via mixed-type inhibition.
- Electron paramagnetic resonance (e.p.r.) spectroscopy reveals concentration-dependent binding interactions.
Conclusions:
- Ranitidine directly interacts with rat liver CYP450 enzymes.
- Ranitidine can modulate the activity of specific CYP450 isoforms, potentially affecting the metabolism of other drugs.
- Understanding these interactions is vital for predicting drug-drug interactions and optimizing therapeutic outcomes.